Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 216 |
|
Muscle Channelopathy Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 4 | 5 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 325 | 316 |
|
Invitae Rhabdomyolysis and Metabolic Myopathy Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 202 | 128 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine United States | 480 | 254 |
|
Invitae Periodic Paralysis Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 18 | 6 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine United States | 525 | 338 |
|
Comprehensive Neuromuscular Panel PreventionGenetics, part of Exact Sciences United States | 183 | 142 |
|
Primary Periodic Paralysis Panel PreventionGenetics, part of Exact Sciences United States | 4 | 3 |
|
Invitae Comprehensive Myopathy Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 143 | 70 |
|
Invitae Comprehensive Neuromuscular Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 353 | 208 |
|
GeneSeq® Neuro: Hypokalemic and Hyperkalemic Periodic Paralysis Panel MNG Laboratories (Medical Neurogenetics, LLC.) United States | 6 | 5 |
|
Baylor Genetics United States | 1 | 142 |
|
Genomic Unity® Renal Disorders Analysis Variantyx, Inc. United States | 1 | 425 |
|
Neuromuscular diseases panel_v.2.0 CGC Genetics Unilabs Portugal | 17 | 248 |
|
CGC Genetics Unilabs Portugal | 1 | 181 |
|
CGC Genetics Unilabs Portugal | 1 | 13 |
|
Hypokalemic periodic paralysis (deletion/duplication analysis on CACNA1S and SCN4A genes) CGC Genetics Unilabs Portugal | 1 | 2 |
|
Neuromuscular Diseases Panel (Expanded) Mendelics Brazil | 1 | 288 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.